Related Experiment Video
Updated: Jun 20, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Innovating Cancer Treatment Through Cell Cycle, Telomerase, Angiogenesis, and Metastasis
Tooba Yousefi1,2, Bahareh Mohammadi Jobani1,2, Reyhaneh Taebi1,2
1Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Innovative cancer therapies target cell cycle dysregulation, overactive telomerase, tumor angiogenesis, and metastasis. Understanding these hallmarks offers new hope for improved oncology treatments and patient quality of life.
Area of Science:
- Oncology
- Cancer Biology
- Therapeutic Strategies
Background:
- Cancer is a major medical challenge requiring novel treatment approaches.
- Cell cycle dysregulation drives uncontrolled cancer cell proliferation.
- Hallmarks of cancer include telomerase overactivity, angiogenesis, and metastasis, which are critical for tumor growth and spread.
Purpose of the Study:
- To review key aspects of cancer biology relevant to therapeutic interventions.
- To highlight innovative strategies targeting cell cycle, telomerase, angiogenesis, and metastasis.
- To underscore the importance of understanding cancer hallmarks for treatment advancement.
Main Methods:
- This review synthesizes current research on cancer hallmarks.
- It examines therapeutic strategies targeting cell cycle regulation.
- It discusses interventions for telomerase activity, angiogenesis, and metastasis.
Main Results:
- Dysregulated cell cycle control is a key factor in cancer development.
- Telomerase overactivity confers immortality to cancer cells.
- Inhibiting angiogenesis and metastasis are crucial for controlling tumor progression.
Conclusions:
- Targeting cell cycle, telomerase, angiogenesis, and metastasis represents a multifaceted approach to cancer therapy.
- Continued research into these areas is vital for improving cancer treatment outcomes.
- Advancements in oncology offer hope for enhanced patient survival and quality of life.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy

